Previous 10 | Next 10 |
home / stock / bayry / bayry news
2023-08-22 00:06:59 ET Summary Bayer reporting disappointing second quarter results with declining sales and lowered the guidance for fiscal 2023. The company is continuing to struggle and total debt increased again and management is now expecting no free cash flow in 2023. Bu...
2023-08-21 15:58:31 ET More on Eli Lilly Eli Lilly Q2: Dividends Don't Lie Eli Lilly: Q2 And 2023 Revised Guidance Impressive, But Key Is Wegovy Data Eli Lilly and Co ( LLY ) Q2 2023 Earnings Call Transcript Eli Lilly Remains A Buy With Strong Sales And P...
2023-08-18 21:10:28 ET More on Regeneron Regeneron could see share price bounce with potential approvals Regeneron: CRL For High Dose Eylea Gives Vabysmo A Wider Opening Regeneron Pharmaceuticals: Overdependence On Eylea Brought To The Forefront Regeneron: Ey...
2023-08-08 13:23:03 ET Bayer Aktiengesellschaft (BAYZF) Q2 2023 Earnings Call Transcript August 08 2023, 08:00 AM ET Company Participants Oliver Maier - Head of IR Bill Anderson - CEO Wolfgang Nickl - CFO Rodrigo Santos - President, Crop Science Division ...
2023-08-08 09:10:00 ET Summary S&P 500 and Dow Jones Industrial Average both saw positive returns of around 3% in July. The Federal Reserve approved a quarter point interest rate hike to 5.5% to combat rising inflation. The inflation rate for the United States was 3.0% for the...
2023-08-08 02:00:48 ET Bayer AG press release ( OTCPK:BAYZF ): Q2 Non-GAAP EPS of €1.22. Revenue of €11.04B (-13.9% Y/Y). EBITDA before special items: €2.5 billion (– 24.5%). Free cash flow at minus €0.5 billion. Group outlook f...
2023-07-27 11:15:00 ET Summary Broyhill Asset Management is a boutique investment firm guided by a disciplined value orientation. We operate outside of the fray and invest with a rational, objective, long-term perspective. Broyhill Asset Management is widening access to its flagsh...
2023-07-24 15:39:00 ET Bayer ( OTCPK:BAYRY ) ( OTCPK:BAYZF ) -4.5% in Monday's trading after lowering its full-year outlook , mostly due to a significant further decline in sales of glyphosate-based products, including its Roundup weedkiller. For FY 2023, Bayer ( OTCPK...
2023-07-13 13:00:43 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Editor’s note: “Nvidia Just Confirmed an Emerging AI Boom in Biotech ” was previously published in June 2023 . It has since been updated to include the most r...
2023-07-13 12:30:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Although mega cap tech...
News, Short Squeeze, Breakout and More Instantly...
Bayer AG ADR Company Name:
BAYRY Stock Symbol:
OTCMKTS Market:
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...